VivoSeq
Oncology

Stage III Rectal Cancer

0

Pipeline Programs↗

1

Active Trials↗

0

Companies Involved↗

Stage III Rectal Cancer is an early-stage landscape with 0 programs across 0 companies.

Intelligence

Pipeline Metrics

Competitive Density

6/100

Pipeline Velocity

0/100

Mech. Concentration

N/A

Completion Rate

80/100

Attrition Rate

14/100

Pipeline

Programs by Phase

No pipeline programs currently tracked for this disease.

Analysis

Trial Status

7

clinical trials

Completed4 · 57%
Unknown status1 · 14%
Active, not recruiting1 · 14%
Withdrawn1 · 14%

Clinical Trials

Trial Activity

7 trials

Radiation Therapy and Fluorouracil With or Without Combination Chemotherapy Followed by Surgery in Treating Patients With Stage II or Stage III Rectal Cancer
Active, not recruiting·MMemorial Sloan Kettering Cancer Center·Phase 2·NCT00335816·248 enrolled
Radiation Therapy and Capecitabine With or Without Oxaliplatin in Treating Patients Who Are Undergoing Surgery for Stage II or Stage III Rectal Cancer
Completed·UUNICANCER·Phase 3·NCT00227747·598 enrolled
Bevacizumab, Fluorouracil, and External-Beam Radiation Therapy in Treating Patients With Stage II or Stage III Rectal Cancer
Completed·National Cancer Institute (NCI)·Phase 1·NCT00052559·32 enrolled
Radiation Therapy With or Without Chemotherapy Before Surgery in Treating Patients With Stage II or Stage III Rectal Cancer
Completed·FFederation Francophone de Cancerologie Digestive·Phase 3·NCT00296608·762 enrolled
Celecoxib, Fluorouracil, and Radiation Therapy in Treating Patients With Stage II or Stage III Rectal Cancer That Can Be Removed By Surgery
Completed·VVanderbilt-Ingram Cancer Center·Phase 2·NCT00336960·24 enrolled
Studying Biomarkers in Tumor Tissue and Blood Samples From Patients Undergoing Chemotherapy and Radiation Therapy for Stage II or Stage III Rectal Cancer That Can Be Removed By Surgery
Withdrawn·BBarbara Ann Karmanos Cancer Institute·Phase 1·NCT00960427
Adjuvant Chemotherapy in Patients With Clinical Stage III Rectal Cancer Undergoing Neoadjuvant Chemoradiotherapy
Unknown status·LLI XIN-XIANG·Phase 3·NCT03415763·764 enrolled

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)